DIAPH1 and neurodegenerative disease: In this section, we delve into how RAGE, Diaph1, and associated ligands show altered expression in ALS and similar neurodegenerative diseases, drawing on transcriptomic, in vitro and in vivo, and proteomic evidence, with a focus on recent developments.